Valuation: ResMed, Inc.

Market Cap 32.43B 28.11B 26.31B 24.01B 45.18B 3,093B 45.94B 309B 121B 1,548B 122B 119B 5,165B P/E 2026
18.7x
P/E 2027 * 19.5x
Enterprise Value 31.56B 27.35B 25.6B 23.36B 43.96B 3,010B 44.69B 300B 118B 1,506B 118B 116B 5,026B EV / Sales 2026
4.84x
EV / Sales 2027 * 5.42x
Free-Float
75.62%
Yield 2026
1.26%
Yield 2027 * 1.18%
1 day+2.18%
1 week+0.76%
Current month+6.57%
1 month+10.29%
3 months+13.12%
6 months-13.40%
Current year-6.66%
1 week 202
Extreme 202
226.12
1 month 190.21
Extreme 190.21
226.12
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
5/8/26 Sell

Founder

-8,000 0.0055%
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%+0.76%-20.92%+25.28% 32.43B
+0.89%+7.13%+30.84%+11.26% 224B
-0.92%+6.50%+3.84%-18.78% 146B
+2.00%+8.95%-14.97%+31.77% 142B
+1.45%+4.28%-50.18%+0.31% 74.19B
+1.77%+4.53%+19.83%+17.94% 53.99B
-0.66%+0.23%-15.00%-16.51% 50.85B
+0.52%+7.39%+30.98%+17.84% 42.22B
+0.78%+4.78%+48.59%+42.29% 40.75B
-0.26%+3.54%-0.34%+1.62% 32.86B
Average +0.67%+4.85%+3.27%+11.30% 83.86B
Weighted average by Cap. +0.59%+6.02%+5.39%+9.28%

Financials

2026 2027 *
Net sales 5.65B 4.89B 4.58B 4.18B 7.87B 539B 8B 53.73B 21.05B 270B 21.21B 20.75B 900B 5.81B 5.04B 4.72B 4.3B 8.1B 554B 8.23B 55.29B 21.66B 277B 21.82B 21.35B 926B
Net income 1.54B 1.34B 1.25B 1.14B 2.15B 147B 2.18B 14.65B 5.74B 73.55B 5.78B 5.66B 245B 1.63B 1.41B 1.32B 1.21B 2.27B 155B 2.31B 15.49B 6.07B 77.74B 6.11B 5.98B 259B
Net Debt -877M -760M -712M -649M -1.22B -83.65B -1.24B -8.34B -3.27B -41.87B -3.29B -3.22B -140B -949M -822M -770M -702M -1.32B -90.48B -1.34B -9.02B -3.54B -45.29B -3.56B -3.48B -151B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
11/08/26 US$224.84 +2.18% 1,239,266
10/08/26 US$220.05 +3.83% 1,715,960
07/08/26 US$211.94 -5.06% 3,810,438
06/08/26 US$223.24 -0.35% 1,786,085
05/08/26 US$224.03 +0.40% 1,746,578
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
224.84USD
Average target price
247.20USD
Spread / Average Target
+9.94%

Quarterly revenue - Rate of surprise